ICAAC in Denver 2013

Thursday, 12 September 2013 16:05

High Dose Therapy for Influenza Drug ICAAC 2013

Posted by:

Critically ill patients with the pandemic H1N1 influenza who received triple the standard dose of the influenza drug oseltamivir were 7 times more likely to completely clear the virus from their system in 5 days than those who received the standard dose. This discussion addresses the healthcare implications of these findings, including a rationale for high dose therapy of sensitive strains of influenza.

MALDI-TOF is increasingly being used in clinical microbiology laboratories for rapid bacterial and fungal identification. Participants discuss this new technology and how implementation can drastically change clinical care of some infections.

Thursday, 12 September 2013 15:45

This Week in Virology 250 - Wookie Viruses

Posted by:

This Week in Virology at the 53rd ICAAC in Denver, talking about polyomaviruses.

TWiM at ICAAC 2013. Guests discuss E. coli, one of the most commonly isolated organisms in the clinical microbiology laboratories, and rhinoviruses, agents of the common cold and lower respiratory tract disease.

Wednesday, 11 September 2013 15:56

Pertussis on Rise in U S Elderly ICAAC 2013

Posted by:

Results of a new study estimating that between 2006 and 2010, the incidence of cough illnesses attributed to B. pertussis has nearly doubled in Americans aged 50-64 and more than doubled in Americans over the age of 65.

There is much interest in the role of nutrients and micronutrients in the support of host defense against infections. However, there is controversy in the ability of supplements to help prevent or treat infections. Speakers discuss research on the role of vitamin D supplements to prevent and/or treat recurrent ear infections in children and even the common cold.